Concepedia

A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2– advanced breast cancer (BELLE-4)

Miguel Martín, A. Chan, Luc Dirix, Joyce O’Shaughnessy, Roberto Hegg, Alexey Manikhas, Mikhail Shtivelband, Petr Krivorotko, Norberto Batista López, Mario Campone,

Annals of Oncology · 2016 · 185 citations · 13 references

DOIFull text

Open access

Concepts

References

13

The National Comprehensive Cancer Network

William T. McGivney · Cancer · 1998 · 16.9K citations

, , +15

Comprehensive molecular portraits of human breast tumours

Nature · 2012 · 12.4K citations · Full text

, , +14

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text

, , +13

Subclonal diversification of primary breast cancer revealed by multiregion sequencing

Lucy Yates, Moritz Gerstung, Stian Knappskog et al. · Nature Medicine · 2015 · 840 citations · Full text

, , +16

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

Fátima Cardoso, A. Costa, Larry Norton et al. · Annals of Oncology · 2014 · 539 citations · Full text

, , +15